• Association between brain-derived neurotrophic factor (BDNF) levels in 2 nd trimester amniotic fluid and fetal development 

      Antonakopoulos N., Iliodromiti Z., Mastorakos G., Iavazzo C., Valsamakis G., Salakos N., Papageorghiou A., Margeli A., Kalantaridou S., Creatsas G., Deligeoroglou E., Vrachnis N. (2018)
      The development of the fetal nervous system mirrors general fetal development, comprising a combination of genetic resources and effects of the intrauterine environment. Our aim was to assess the 2 nd trimester amniotic ...
    • BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm 

      Siokas V., Kardaras D., Aloizou A.-M., Asproudis I., Boboridis K.G., Papageorgiou E., Hadjigeorgiou G.M., Tsironi E.E., Dardiotis E. (2019)
      A few genetic variants are implicated in the development of blepharospasm (BSP). The precise role of the rs6265 on the brain-derived neurotrophic factor (BDNF) gene on BSP remains controversial. The effect of rs6265 on BSP ...
    • Val66Met polymorphism is associated with decreased likelihood for pediatric headache and migraine 

      Koute V., Michalopoulou A., Siokas V., Aloizou A.-M., Rikos D., Bogdanos D.P., Kontopoulos E., Grivea I.N., Syrogiannopoulos G.A., Papadimitriou A., Hadjigeorgiou G.M., Dardiotis E. (2021)
      Background: Migraine is a complex multifactorial disorder and its pathogenesis still remains unclear. Evidence suggests the involvement of the activated trigeminovascular pathway, in which BDNF seems to play an important ...